Evidence map›Paper›PMID 38094982›Full record

ArticleAfrican journal of laboratory medicine2023

Performance of the automated Sysmex XN-3000 analyser for detecting white blood cell abnormalities in South Africa.

Jasmine Ramiah, Dashini Pillay, Nadine Rapiti

Open access · diamondAbstract read
In one paragraph

Article in African journal of laboratory medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 2 pooled it
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 2 syntheses or guidelines pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Jasmine RamiahDepartment of Haematology, National Health Laboratory Services, Inkosi Albert Luthuli Central Hospital, Durban, South Africa.ORCID https://orcid.org/0000-0003-4714-7862
Dashini PillayDepartment of Haematology, National Health Laboratory Services, Inkosi Albert Luthuli Central Hospital, Durban, South Africa.ORCID https://orcid.org/0000-0001-8800-2112
Nadine RapitiDepartment of Haematology, National Health Laboratory Services, Inkosi Albert Luthuli Central Hospital, Durban, South Africa.ORCID https://orcid.org/0000-0002-7700-6078
University of KwaZulu-Natal · ZANational Health Laboratory Service · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Automated haematology analysers such as the Sysmex XN-3000 (Sysmex Corporation, Kobe, Japan) utilise white blood cell (WBC) flags to identify quantitative and qualitative abnormalities. Owing to clinical and biological factors, the sensitivity and specificity of the flags vary when compared to microscopy, the gold-standard method for assessing peripheral blood smear (PBS) morphology. Objective: This study assessed the performance of the Sysmex XN-3000 haematology analyser in comparison to PBS microscopy for the detection of WBC abnormalities. Methods: We collected 250 random full blood count samples from the haematology laboratory at Inkosi Albert Luthuli Central Hospital, Durban, KwaZulu-Natal, South Africa, from March 2022 to April 2022. The performance of the automated WBC flags of the Sysmex XN-3000 was assessed in comparison to PBS microscopy, and the impact of established clinical variables on the performance of the flags was determined. Results: The sensitivity of the 'blast' flag was 96.3%, and the specificity was 84.9%. The efficiency of the flag was adversely impacted by low white cell counts (< 1.5 × 10 Conclusion: In our setting, PBS microscopy remains necessary to confirm blasts, abnormal lymphocytes, and monocytosis in patients with malignancy, current chemotherapy exposure, low white cell counts, and infection. What this study adds: This study adds evidence that PBS morphology remains the gold standard for confirming WBC abnormalities in patients with a history of malignancy, chemotherapy, and leucopenia.

Indexed as

automated analysersClinical and Laboratory Standards Institute guidelinesFBCflaggingSysmex analyserwhite blood cell flagsXN-series

Identifiers

PMID38094982
PMCPMC10716597
OpenAlexW4384929939

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.